What is SuperDial?
SuperDial operates as an AI-powered solution specifically engineered to automate high-volume outbound healthcare communications. The platform addresses complex administrative bottlenecks, including insurance verification, prior authorization, claims follow-up, credentialing, and provider data management. By integrating directly into existing clinical workflows, SuperDial replaces manual phone-based processes with intelligent, automated systems that improve accuracy and reduce operational costs. Its market position is defined by its ability to handle the nuanced requirements of healthcare data, positioning it as a critical infrastructure layer for hospitals, clinics, and insurance providers seeking to optimize their revenue cycle management.
How much funding has SuperDial raised?
SuperDial has raised a total of $15M across 1 funding round:
Series A
$15M
Series A (2025): $15M with participation from Box Group, Slow, and SignalFire
Key Investors in SuperDial
Box Group
BoxGroup is an early stage investment fund that focuses on technology companies across various sectors including climate, fintech, and software.
Slow
Slow is a venture capital firm that seeks to make minority investments in seed-stage, early-stage, and later-stage companies.
SignalFire
SignalFire is a venture capital firm designed as a technology company, focused on igniting growth for early-stage teams through data, AI, and expert support.
What's next for SuperDial?
Following this major enterprise-level funding, SuperDial is expected to prioritize the scaling of its engineering and sales teams to meet increasing demand for automated healthcare solutions. The strategic roadmap likely includes enhancing the natural language processing capabilities of its AI agents to handle more complex clinical interactions and expanding its integration ecosystem with major electronic health record systems. As the company transitions from its current growth phase, the focus will shift toward achieving broader market penetration and establishing long-term partnerships with large-scale healthcare networks. This capital injection provides the necessary runway to refine its proprietary technology and maintain a competitive edge in the rapidly evolving healthtech landscape.
See full SuperDial company page
